| Validation of a fast method for quantitative analysis of elvitegravir, raltegravir, maraviroc, etravirine, tenofovir, boceprevir and 10 other antiretroviral agents in human … Z Djerada, C Feliu, C Tournois, D Vautier, L Binet, A Robinet, H Marty, ... Journal of Pharmaceutical and biomedical Analysis 86, 100-111, 2013 | 86 | 2013 |
| Population pharmacokinetic-pharmacodynamic modeling of ropivacaine in spinal anesthesia Z Djerada, C Feliu, Y Cazaubon, F Smati, P Gomis, D Guerrot, B Charbit, ... Clinical pharmacokinetics 57, 1135-1147, 2018 | 35 | 2018 |
| Current knowledge on the role of P2Y receptors in cardioprotection against ischemia-reperfusion Z Djerada, C Feliu, V Richard, H Millart Pharmacological Research 118, 5-18, 2017 | 28 | 2017 |
| Complementary role of P2 and adenosine receptors in ATP induced-anti-apoptotic effects against hypoxic injury of HUVECs C Feliu, H Peyret, G Poitevin, Y Cazaubon, F Oszust, P Nguyen, H Millart, ... International journal of molecular sciences 20 (6), 1446, 2019 | 21 | 2019 |
| Quantification of 15 antibiotics widely used in the critical care unit with a LC-MS/MS system: an easy method to perform a daily therapeutic drug monitoring C Feliu, C Konecki, T Candau, D Vautier, C Haudecoeur, C Gozalo, ... Pharmaceuticals 14 (12), 1214, 2021 | 18 | 2021 |
| Population pharmacokinetics of articaine with 1: 200,000 epinephrine during third molar surgery and simulation of high-dose regimens Y Cazaubon, C Mauprivez, C Feliu, L Binet, O Oget, C Gozalo, Z Djerada European Journal of Pharmaceutical Sciences 114, 38-45, 2018 | 18 | 2018 |
| Validation of a fast UPLC–MS/MS method for quantitative analysis of opioids, cocaine, amphetamines (and their derivatives) in human whole blood C Feliu, H Millart, H Guillemin, D Vautier, L Binet, A Fouley, Z Djerada Bioanalysis 7 (20), 2685-2700, 2015 | 18 | 2015 |
| Population pharmacokinetics modelling and simulation of mitotane in patients with adrenocortical carcinoma: an individualized dose regimen to target all patients at three months? Y Cazaubon, Y Talineau, C Feliu, C Konecki, J Russello, O Mathieu, ... Pharmaceutics 11 (11), 566, 2019 | 15 | 2019 |
| External evaluation of population pharmacokinetic models and Bayes-based dosing of infliximab C Konecki, C Feliu, Y Cazaubon, D Giusti, M Tonye-Libyh, H Brixi, ... Pharmaceutics 13 (8), 1191, 2021 | 14 | 2021 |
| Quantification of methadone, buprenorphine, naloxone, opioids, and their derivates in whole blood by liquid chromatography-high-resolution mass spectrometry: Analysis of their … C Feliu, C Konecki, L Binet, D Vautier, C Haudecoeur, O Oget, A Fouley, ... Journal of Chromatography B 1152, 122226, 2020 | 14 | 2020 |
| CRISPR/Cas9-mediated inactivation of the phosphatase activity of soluble epoxide hydrolase prevents obesity and cardiac ischemic injury M Leuillier, T Duflot, S Ménoret, H Messaoudi, Z Djerada, D Groussard, ... Journal of advanced research 43, 163-174, 2023 | 10 | 2023 |
| Therapeutic drug monitoring of mitotane: Analytical assay and patient follow‐up C Feliu, Y Cazaubon, H Guillemin, D Vautier, O Oget, H Millart, C Gozalo, ... Biomedical Chromatography 31 (11), e3993, 2017 | 10 | 2017 |
| Renal impairment and abnormal liver function tests in pre-therapeutic phenotype-based DPD deficiency screening using uracilemia: a comprehensive population-based study in 1138 … S Callon, M Brugel, D Botsen, B Royer, F Slimano, C Feliu, C Gozalo, ... Therapeutic Advances in Medical Oncology 15, 17588359221148536, 2023 | 9 | 2023 |
| Ticagrelor prevents endothelial cell apoptosis through the adenosine signalling pathway in the early stages of hypoxia C Feliu, H Peyret, S Brassart-Pasco, F Oszust, G Poitevin, P Nguyen, ... Biomolecules 10 (5), 740, 2020 | 9 | 2020 |
| Association between clozapine plasma concentrations and treatment response: a systematic review, meta-analysis and individual participant data meta-analysis F Tralongo, C Konecki, C Feliu, A Kaladjian, Z Djerada Clinical Pharmacokinetics 62 (6), 807-818, 2023 | 8 | 2023 |
| Impact of guidelines regarding dihydropyrimidine dehydrogenase (DPD) deficiency screening using uracil-based phenotyping on the reduction of severe side effect of 5 … N Laures, C Konecki, M Brugel, AL Giffard, N Abdelli, D Botsen, C Carlier, ... Pharmaceutics 14 (10), 2119, 2022 | 8 | 2022 |
| Drowsiness and uncommon fever in a child after cannabis ingestion C Feliu, Y Cazaubon, A Fouley, H Guillemin, H Millart, C Gozalo, ... Annales de Biologie Clinique 75 (4), 462-465, 2017 | 8 | 2017 |
| About 5 cases with 3 Meo-PCP including 2 deaths and 3 non-fatal cases seen in France in 2018 F Grossenbacher, Y Cazaubon, C Feliu, A Ameline, P Kintz, O Passouant, ... Toxicologie Analytique Et Clinique 31 (4), 332-336, 2019 | 7 | 2019 |
| High‐Dose Mitotane‐Induced Encephalopathy in the Treatment of Adrenocortical Carcinoma E Pape, C Feliu, M Yéléhé‐Okouma, N Colling, Z Djerada, N Gambier, ... The Oncologist 23 (3), 389-390, 2018 | 7 | 2018 |
| Clinical and analytical toxicology of opiate, cocaine and amphetamine C Feliu, A Fouley, H Millart, C Gozalo, H Marty, Z Djerada Annales de Biologie Clinique 73 (1), 54-69, 2015 | 7 | 2015 |
